Home » Newsletters » BioWorld

BioWorld

Oct. 28, 1996

View Archived Issues

ALKERMES TO RECEIVE $20M IN EXPANDED DEAL WITH JOHNSON & JOHNSON

GENETIC TESTING MAY BE HAZARDOUS TO LIVELIHOOD

RESEARCH THAT UNLOCKS KEY TO COMPRESSING DNA JUMP-STARTS NEW BIOTECH

EQUITY MARKETS SHOW A PULSE AS SUGEN, LIGAND COMPLETE OFFERINGS

CUBIST SETTLES FOR $6 PER SHARE IN COMPLETING $15M IPO

CHIRON POSTS EARNINGS GAIN, BUT FIGURES HAVE DOUBLE MEANING